Since its introduction in 1977, percutaneous coronary intervention has become one of the
most commonly performed therapeutic procedures worldwide. Such widespread diffusion …

Dual antiplatelet therapy with aspirin and clopidogrel is currently the standard therapy after
coronary stent implantation to prevent a life-threatening stent thrombosis. However, a variety …

Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …

Percutaneous coronary intervention (PCI) is the most commonly performed invasive
therapeutic cardiac procedure and plays an important role in the treatment of ischemic heart …

Percutaneous coronary intervention (PCI) has become a standard-of-care procedure in the
setting of angina or acute coronary syndrome. Antithrombotic therapy is the cornerstone of …

Antithrombotic agents are an integral component of the medical regimens and interventional
strategies currently recommended to reduce thrombotic complications in patients with acute …

This chapter about antithrombotic therapy during percutaneous coronary intervention (PCI)
is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy …

Dual antiplatelet treatment with aspirin and clopidogrel is recommended after coronary
stenting (PCI-S). There is scant evidence defining optimal post-PCI-S antithrombotic therapy …

Multiple guidelines and consensus papers have addressed the role of antithrombotic
strategies in patients with established coronary artery disease (CAD). Since evidence and …